Europe: Groundbreaking embryonic stem cell study gets green light
27/9/2011
U.K. regulators have given the green light to a small but groundbreaking embryonic stem cell treatment advanced by the Marlborough, MA-based biotech Advanced Cell Technology for Stargardt's macular dystrophy, an incurable disease. This is the first such ESC trial in Europe. More...
Author: Greer Deal, Director of Global Regulatory Services (GRS)